WARRANTS (Tables)
|
6 Months Ended |
12 Months Ended |
Sep. 30, 2018 |
Mar. 31, 2018 |
Warrants and Rights Note Disclosure [Abstract] |
|
|
Schedule Of Share Based Compensation Stock Purchase Warrants Activity [Table Text Block] |
The following is a continuity schedule of the Company’s common share purchase warrants:
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable, March 31, 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable, March 31, 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable, March 31, 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued in connection with anti-dilution provision connected to warrant transaction |
|
|
|
|
|
|
|
|
Issued in connection with anti-dilution provision connected to warrant transaction |
|
|
|
|
|
|
|
|
Issued in connection to the warrant transaction to the broker |
|
|
|
|
|
|
|
|
Issued in connection with the conversion of loans and interest into common shares |
|
|
|
|
|
|
|
|
Issued in connection with the conversion of loans and interest into common shares |
|
|
|
|
|
|
|
|
Issued in connection with anti-dilution provision connected to warrant transaction |
|
|
|
|
|
|
|
|
Issued in connection with anti-dilution provision connected to warrant transaction |
|
|
|
|
|
|
|
|
Outstanding at March 31, 2018 |
|
|
|
|
|
|
|
|
Issued in connection with anti-dilution provision connected to warrant transaction |
|
|
|
|
|
|
|
|
Issued in connection with anti-dilution provision connected to warrant transaction |
|
|
|
|
|
|
|
|
Outstanding at September 30, 2018 |
|
|
|
|
|
|
|
|
|
The following is a continuity schedule of the Company’s common share purchase warrants :
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable, March 31, 2015 |
|
|
72,157 |
|
|
|
202.50 |
|
Issued |
|
|
48,171 |
|
|
|
202.50 |
|
Exercised |
|
|
(992 |
) |
|
|
(120.00 |
) |
Outstanding and exercisable, March 31, 2016 |
|
|
119,336 |
|
|
|
202.50 |
|
Exercised |
|
|
(1,747 |
) |
|
|
(120.00 |
) |
Outstanding and exercisable, March 31, 2017 |
|
|
117,589 |
|
|
|
202.50 |
|
Exercised |
|
|
(33,335 |
) |
|
|
(37.50 |
) |
Issued in connection with anti-dilution provision connected warrant transaction |
|
|
559 |
|
|
|
112.35 |
|
Issued in connection with anti-dilution provision connected warrant transaction |
|
|
6,275 |
|
|
|
194.00 |
|
Issued in connection to the warrant transaction to the broker |
|
|
2,667 |
|
|
|
37.50 |
|
Issued in connection with conversion of loans and interest into common shares |
|
|
106,709 |
|
|
|
9.375 |
|
Issued in connection with conversion of loans and interest into common shares |
|
|
15,658 |
|
|
|
90.00 |
|
Issued in connection with anti-dilution provision connected with issuance of common shares |
|
|
136,388 |
|
|
|
73.02 |
|
Issued in connection with anti-dilution provision connected with issuance of common shares |
|
|
13,464 |
|
|
|
44.28 |
|
Outstanding and exercisable, March 31, 2018 |
|
|
365,974 |
|
|
$ |
53.19 |
|
|
Schedule of Common Share Purchase Warrants Outstanding [Table Text Block] |
The following is a summary of common share purchase warrants as of September 30, 2018:
|
The following is a summary of common share purchase warrants outstanding after the warrant offer to amend and exercise the additional warrant issue and the re-pricing of the warrants as of March 31, 2018.
|
|
|
|
|
|
90.00 |
|
|
15,658 |
|
|
March 31, 2023 |
73.02 |
|
|
104,019 |
|
|
February 26, 2019 |
73.02 |
|
|
21,768 |
|
|
March 27, 2019 |
73.02 |
|
|
5,813 |
|
|
March 31, 2019 |
73.02 |
|
|
45,061 |
|
|
April 21, 2019 |
73.02 |
|
|
21,274 |
|
|
May 27, 2019 |
73.02 |
|
|
20,782 |
|
|
June 30, 2019 |
44.28 |
|
|
22,223 |
|
|
February 26, 2019 |
37.50 |
|
|
2,667 |
|
|
June 27, 2020 |
9.375 |
|
|
64,025 |
|
|
August 14, 2022 |
9.375 |
|
|
42,684 |
|
|
March 31, 2022 |
|
|
|
365,974 |
|
|
|
|
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90.00 |
|
|
15,658 |
|
|
|
31-Mar-23 |
|
|
|
5 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
116,142 |
|
73.02 |
|
|
104,019 |
|
|
|
26-Feb-19 |
|
|
|
0.92 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
100,281 |
|
73.02 |
|
|
21,768 |
|
|
|
27-Mar-19 |
|
|
|
1 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
24,815 |
|
73.02 |
|
|
5,813 |
|
|
|
31-Mar-19 |
|
|
|
1 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
6,769 |
|
73.02 |
|
|
45,061 |
|
|
|
21-Apr-19 |
|
|
|
1.08 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
58,358 |
|
73.02 |
|
|
21,274 |
|
|
|
27-May-19 |
|
|
|
1.16 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
32,276 |
|
73.02 |
|
|
20,782 |
|
|
|
30-Jun-19 |
|
|
|
1.25 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
36,116 |
|
44.28 |
|
|
22,223 |
|
|
|
26-Feb-19 |
|
|
|
0.92 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
38,423 |
|
9.375 |
|
|
64,025 |
|
|
|
14-Aug-22 |
|
|
|
4.38 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
593,355 |
|
9.375 |
|
|
42,684 |
|
|
|
31-Mar-22 |
|
|
|
4 |
|
|
|
1.59 |
% |
|
|
0 |
% |
|
|
0 |
% |
|
|
135 |
% |
|
|
387,529 |
|
|
|
|
363,307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,394,164 |
|
|